glp-1 receptor agonist type 1 diabetes randomized trial Association of glucagon-like peptide-1 agonists with atrial fibrillation, cardiac arrest, and ventricular fibrillation: Casual evidence from a drug target Mendelian randomization | Diabetology & Metabolic Syndrome Management of type 2 diabetes

But they work through fundamentally different mechanisms, carry different costs, and have different evidence profiles

Inter-individual Variation in Hepatic Drug Metabolism

66 Adoptive NK- or CAR-T-based approaches and CD3 bispecific antibodies (BsAbs) are currently being evaluated in preclinical studies and early-phase clinical trials

Research into these natural antioxidants offers promising avenues for preventive and therapeutic strategies against oxidative stress-related diseases [18]

GHK-Cu delivers copper as a cofactor for lysyl oxidase and lysyl hydroxylase, two enzymes essential for crosslinking collagen chains into stable, load-bearing structures